American driver Jak Crawford will be Aston Martin's third driver for the 2026 Formula 1 season, effectively acting as reserve to Fernando Alonso and Lance Stroll should either be unable to race.

American youngster Jak Crawford has inched closer to a Formula 1 drive by stepping up to the role of Aston Martin’s reserve driver. Crawford, 20, joined Aston Martin’s young driver development program ...

For much of the 2025 season, Jak Crawford has been considered the next American hopeful for Formula One. The last American to compete in the pinnacle of motorsport was Logan Sargeant, who raced for ...

AUSTIN -- Rising American racing star Jak Crawford will drive in first practice for Aston Martin ahead of Formula 1's Mexico City Grand Prix next week. Crawford, 20, will take Lance Stroll's seat in ...

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...

Jak Roberto clarified that he is not courting his "My Father's Wife" co-star Kylie Padilla. The Sparkle star guested on "Fast Talk with Boy Abunda" Friday where he was candidly asked by Tito Boy if he ...

A meta-analysis showed no significant differences between JAK inhibitor use and TNF antagonist use in terms of the risk for serious infections or malignant neoplasms in patients with immune-mediated ...

Maddie Fisher is a writer, journalist and game developer. She was born and raised on the east coast, having started working in games journalism over fifteen years ago. She tends to enjoy musical ...

English actor Jak Malone delivered a powerful message about accepting transgender people for who they are during the 2025 Tony Awards. Malone took the stage at Radio City Music Hall in New York City ...

Jak Malone wins his first Tony Award for Best Featured Actor in a Musical for his Broadway debut in Operation Mincemeat where he plays Hester Leggatt and more. He originated the role in London and has ...

Ruxolitinib cream shows comparable efficacy to systemic therapies in reducing disease severity in moderate atopic dermatitis, with significant BSA reduction over 7.4 months. Abrocitinib demonstrates ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...